Coeptis Therapeutics, Inc. (COEP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 60.35M |
| Enterprise Value | 54.94M |
| P/E Ratio | -7.53 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 36.85 |
| Price/Book Ratio | 5.21 |
| Enterprise/Revenue | 33.24 |
| Enterprise/EBITDA | -4.32 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.4 |
| Operating Margin | -9.12 |
| Return On Assets | -0.6 |
| Return On Equity | -0.9 |
| Revenue | 1.36M |
| Revenue/Share | 0.23 |
| Gross Profit | 1.18M |
| EBITDA | -10.41M |
| Net Income | -11.92M |
| Diluted EPS | -2.81 |
| Total Cash | 5.26M |
| Total Cash/Share | 0.87 |
| Total Debt | 100,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.25 |
| Book Value Per Share | 3.22 |
| 52-Week Change | 80.63 |
| 52-Week High | 21.41 |
| 52-Week Low | 6.8 |
| Moving Average 50 Days | 12.25 |
| Moving Average 200 Days | 13.72 |
| Average Volume | 50,880 |
| Shares Outstanding | 3.51M |
| % Held by Institutions | 0.17 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | December 31, 2024 |